Global estimates on the number of persons across the Alzheimer's disease continuum

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease

Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575

Mild cognitive impairment – Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment.

Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689

Study on the Relationship between Cerebral Blood Perfusion, Neuronal Cytokines and Cognitive Function in Patients with Alzheimer's Disease

Lu, H., Fang, Y., Chen, X., Zhang, W., & Wang, Y. (2024) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v52i3.1630 · Cited by 4

Frontiers and hotspots evolution in anti-inflammatory studies for Alzheimer’s disease

Wu, S., Chen, N., & Wang, C. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115178 · Cited by 4

Magnetic stirring with iron oxide nanospinners accretes neurotoxic Aβ42 oligomers into phagocytic clearable plaques for Alzheimer's disease treatment

Sabu, A., Huang, Y. C., Sharmila, R., Sun, C.-Y., Shen, M.-Y., & Chiu, H. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101213 · Cited by 4

Research Trends in Application of Artificial Intelligence in Alzheimer’s Disease: Bibliometric and Visualization Analysis

Yang, X., Xu, X., & Ying, J. (2024) · IEEE International Conference on Big Data and Artificial Intelligence (BDAI) · doi:10.1109/bdai62182.2024.10692826 · Cited by 4

Amyloid-β deposition predicts oscillatory slowing of magnetoencephalography signals and a reduction of functional connectivity over time in cognitively unimpaired adults

Scheijbeler, E. P., de Haan, W., Coomans, E. M., den Braber, A., Tomassen, J., ten Kate, M., Konijnenberg, E., Collij, L. E., van de Giessen, E., Barkhof, F., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf018 · Cited by 4

The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease

Wuli, W., Yang, H., Chiou, T., Woon, P. Y., Xu, Y., Tjandra, C., Wijaya, I., Harn, H., & Lin, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073382 · Cited by 4

Nanomedicine for Treating Major Brain Diseases: Advances and Future Directions

Sagar, G., Wilson, B., Mukundan, G. K., Divekar, K., & Jenita⃰, J. J. L. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00277 · Cited by 4

Clinical Performance of the Elecsys CSF pTau181/Aβ42 Ratio for Concordance with Tau-PET in Two Independent Cohorts

Smith, R. A., Shaw, L. M. J., Palmqvist, S., Mattsson, N., Klein, G., Tonietto, M., Initiative, A. D. N., Quijano‐Rubio, C., Rank, C. M., Andreadou, M., et al. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00798-8 · Cited by 4

Investigation of Methylsulfonamide’s Capability to Prevent Zn 2+ -Induced Aβ Peptide Aggregation Based on Zn 2+ Coordination within the Zinc Binding Region of Aβ for Treatment of Alzheimer’s Disease (AD)

Ataman, D., Cansız, C. S., Turğut, M., Dağ, Ç., & Duman, M. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00238 · Cited by 4

Plasma ceramide mediates the association of peripheral T cells with Alzheimer’s disease

Sun, Y., Xia, L., Xu, X.-F., Wang, X., Guo, J., Cheng, R., Yang, N., Shen, L., Liu, N., Mo, X., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.027 · Cited by 5

Role of dietary phytopharmaceuticals across the globe to alleviate the Alzheimer’s disease: mechanism-based approach

Mishra, A. K., Mishra, A., Kamal, Y. T., Kumar, A., Singh, H., Verma, S., & Khan, G. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100877 · Cited by 4

Multi-Stage Alzheimer’s Disease Prediction Using Multihead Attention based CNN-BiGRU with XAI

Karim, M. R., & Islam, R. (2025) · International Conference on Next-Generation Computing, IoT and Machine Learning (NCIM) · doi:10.1109/ncim65934.2025.11159870 · Cited by 4

Pathophysiological mechanisms linking osteoarthritis and neurodegenerative disease risk

Prasoon, P., Nguyen, K. L., Fathi, P. A., Gupta, S., Arnab, S., Jones, E. C., Meyyappan, A., Stehle, E. J., & Bethea, J. R. (2025) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2025.10.009 · Cited by 4

Stimulus material selection for the Dutch famous faces test for older adults

van den Elzen, E. H. T., Brehmer, Y., Deun, K. V., & Mark, R. E. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1124986 · Cited by 4

Physical Performance and Amyloid-β in Humans: A Systematic Review and Meta-Analysis of Observational Studies

Solis‐Urra, P., Rodríguez‐Ayllón, M., Álvarez-Ortega, M., Molina‐Hidalgo, C., Molina‐García, P., Arroyo‐Avila, C., García‐Hermoso, A., Collins, A. M., Jain, S., Gispert, J. D., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230586 · Cited by 4

Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom Onset

Palade, J., Alsop, E. B., Courtright-Lim, A., Hsieh, M., Whitsett, T. G., Galasko, D. R., & Keuren‐Jensen, K. R. V. (2024) · Cells · doi:10.3390/cells13030207 · Cited by 4

Alzheimer’s Disease in Lebanon: Exploring Genetic and Environmental Risk Factors—A Comprehensive Review

Khaled, M., Al-Jamal, H., Tajer, L., & El-Mir, R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231432 · Cited by 4

Apolipoprotein E4 interferes with lipid metabolism to exacerbate depression‐like behaviors in 5xFAD mice

Gong, Y., Li, M., Liu, M., Wu, X., Li, Y., Qin, C., & Zhang, L. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12446 · Cited by 3

Alzheimer’s Disease: Engaging with an Unstable Category

Daly, T. P., & Keuck, L. (2024) · Springer eBooks · doi:10.1007/978-94-017-8706-2_113-1 · Cited by 5

Omics‐derived biological modules reflect metabolic brain changes in Alzheimer's disease

Povala, G., Bastiani, M. A. D., Bellaver, B., Ferreira, P. C. L., Ferrari‐Souza, J. P., Lussier, F. Z., Souza, D. O., Rosa‐Neto, P., Pascoal, T. A., Zatt, B., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14095 · Cited by 3

Complex regulation of tau phosphorylation by the endothelin system in brain microvascular endothelial cells (BMVECs): link to barrier function

Karakaya, E., Abdul, Y., Edwards, J. M., Jamil, S., Albayram, Ö., & Ergul, A. (2024) · Clinical Science · doi:10.1042/cs20240616 · Cited by 5

The Role of Epileptic Activity in Alzheimer’s Disease

Chen, T., Lai, M., Hong, W., & Huang, C. (2024) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175241303569 · Cited by 4

Correlations between SHBG, Sex Hormones, Inflammation, and Neurocognitive Decline in Alzheimer's Disease: A Retrospective Study

Jin, J., Lü, L., Hua, K., Fang, L., Li, X., & Li, W. (2024) · Current Alzheimer Research · doi:10.2174/0115672050341904241111082935 · Cited by 5

Mapping the current trends and hotspots of extracellular vesicles in Alzheimer's disease: a bibliometric analysis

Xing, X., Liu, H., Zhang, M., & Li, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1485750 · Cited by 5

Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease

Bendetowicz, D., Planche, V., Bézard, E., Dehay, B., & Meissner, W. G. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241313443 · Cited by 4

Rational design, docking, simulation, synthesis, and in vitro studies of small benzothiazole molecules as selective BACE1 inhibitors

Afzal, O., Alamri, M. A., Altharawi, A., Alossaimi, M. A., Mohamed, M. A., Altamimi, A. S. A., Asfour, H. Z., Alhakamy, N. A., & Firoz, A. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2472402 · Cited by 4

2024 Alzheimer's Association criteria for Alzheimer's disease diagnosis are usually anchored to both plaques and tangles, not Aβ alone

Jack, C. R., Knopman, D. S., Wiste, H. J., Sperling, R. A., Jagust, W. J., Murray, M. E., Boon, B. D. C., Lowe, V. J., Johnson, D. R., Burkett, B. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70184 · Cited by 4

Early Diagnosis of Alzheimer's Disease Using YOLOv11 Deep Learning Model in MRI Scans

Hechkel, W., Missaoui, R., & Helali, A. (2025) · International Multi-Conference on Systems, Signals & Devices (SSD) · doi:10.1109/ssd64182.2025.10989989 · Cited by 4

Improving Early Detection of Dementia: Extra Trees-Based Classification Model Using Inter-Relation-Based Features and K-Means Synthetic Minority Oversampling Technique

Chaiyo, Y., Rueangsirarak, W., Hristov, G., & Temdee, P. (2025) · Big Data and Cognitive Computing · doi:10.3390/bdcc9060148 · Cited by 4

Multivariate empirical mode decomposition reveals markers of Alzheimer’s Disease in the oscillatory response to transcranial magnetic stimulation

Bernardi, D., Casula, E. P., Rocchi, L., Fadiga, L., Koch, G., & Papo, D. (2025) · Clinical Neurophysiology · doi:10.1016/j.clinph.2025.2110756 · Cited by 4

Bone marrow-derived myeloid cells drive neuroinflammation in Alzheimer's disease: Insights from the FAD4T mouse model

Pang, Y., Jia, D., Ye, F., Liu, F., Li, J., Zhu, S., Wang, B., Yao, M., Du, L., Yang, C., et al. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.06.014 · Cited by 4

The association between dual sensory impairment and dementia: a meta-analysis and systematic review of the literature

Zumbrunn, N. M., Beckett, K., Karl, J. A., Newell, F. N., Hopper, L., & McGovern, D. P. (2025) · Age and Ageing · doi:10.1093/ageing/afaf267 · Cited by 4

An Update on Parkinson’s Disease and its Neurodegenerative Counterparts

Adam, H., Gopinath, S. C. B., Arshad, M. K. M., Adam, T., Subramanıam, S., & Hashim, U. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230403085733 · Cited by 4

The promising role of bioactive congeners present in Cassytha filiformis in Alzheimer's disease: An explicative review

Khabiya, R., Karati, D., Dwivedi, S., Dwivedi, A., & Mukherjee, S. (2024) · Brain Disorders · doi:10.1016/j.dscb.2024.100125 · Cited by 4

Identification of disease-specific bio-markers through network-based analysis of gene co-expression: A case study on Alzheimer's disease

Zheng, H., Gu, C., & Yang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27070 · Cited by 5

Hydrazide‐Bridged Pyridazines for Cholinesterase Inhibitors: Synthesis, Characterizations, In Silico, and In Vitro Evaluation

Gürsoy, Ş., Önel, G. T., Türkmenoğlu, B., Merde, İ. B., Dilek, E., Hepokur, C., & Algül, Ö. (2024) · ChemistrySelect · doi:10.1002/slct.202400085 · Cited by 4

Single-molecule characterisation of soluble beta-amyloid aggregate binding by Aducanumab, Lecanemab, Gantenerumab, and DonanemabPreprint

Fertan, E., Lam, J. Y. L., Albertini, G., Dewilde, M., Wu, Y., Akingbade, O. E. S., Böken, D., English, E. A., Strooper, B. D., & Klenerman, D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.11.617910 · Cited by 4

Cell type transcriptomics reveal shared genetic mechanisms in Alzheimer’s and Parkinson’s diseasePreprint

Bhattacharya, A., Fon, E. A., Dagher, A., Iturria‐Medina, Y., Stratton, J. A., Savignac, C., Stanley, J., Hodgson, L. M., Hammou, B. A., Bennett, D. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.17.638647 · Cited by 4

Synergistic effect of folate and MTHFR C677T on hippocampal subfields and perfusion in Alzheimer's disease

Tang, Y., Zhou, X., Cao, J., Li, Z., Yin, W., Wan, K., Huang, C., Zhu, W., Yin, J., Zhang, W., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111071 · Cited by 3

Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?

Correia, S. C., Perry, G. L., & Moreira, P. I. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240787 · Cited by 3

Effects of resistance exercise on behavioral and molecular changes in transgenic female mice for Alzheimer's disease in early and advanced stages

da Silva, E. A., Faber, J., Penitente, A. R., Fernandes, J., Bertolucci, P. H. F., Longo, B. M., & Arida, R. M. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115217 · Cited by 3

Mechanisms and Characteristics of Chronic Pain in Alzheimer’s Disease: A Narrative Review

Konovalov, R., Aubakirova, M., & Viderman, D. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673334477250204072429 · Cited by 3

FROG: A Fine-Grained Spatiotemporal Graph Neural Network With Self-Supervised Guidance for Early Diagnosis of Alzheimer's Disease

Zhang, S., Wang, Q., Wei, M., Zhong, J., Zhang, Y., Song, Z., Li, C., Zhang, X., Han, Y., Li, Y., et al. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3552638 · Cited by 3

Altered Composition of Ceramides and Sphingomyelin Distinctly Modulates the Organizational Landscape and Microdomain Dynamics of Neuronal Plasma Membrane: A Computational Microscopy of Alzheimer’s Brain

Peesapati, S., & Chakraborty, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00261 · Cited by 2

Preclinical evidence and potential mechanisms of tanshinone ⅡA on cognitive function in animal models of Alzheimer’s disease: a systematic review and meta-analysis

Rong, Y., Li, Q., Du, Y., Wang, W., Su, W., Zhang, J., & He, W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1603861 · Cited by 3

Optimized sequential classification models for mild cognitive impairment screening based on handwriting and speech data

Tang, Q., Zhang, X., Zhang, C., Lang, Q., Qi, H., & Wang, L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251359874 · Cited by 3

Targeting the root cause of obesity-related comorbidities through weight independent and dependent actions on insulin sensitivity: Benefits of dual amylin and calcitonin receptor agonists

Larsen, A. T., Melander, S. A., Mohamed, K. E., Petersen, E. A., Benmarce, M., Karsdal, M. A., & Henriksen, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118388 · Cited by 3

Bio-Functionalities of Sesame (Sesamum indicum L.) Seed Meal and Proteins: Illuminating Their Novel Role and Mechanisms as Versatile Functional Food Ingredients for Health Promotion

Eze, F. N., Muangrat, R., Jirarattanarangsri, W., Siriwoharn, T., & Chalermchat, Y. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00693-6 · Cited by 3

Dantrolene normalizes heightened Ca2+ influx in activated T cells from the familial Alzheimer's disease TgF344-AD rats

Uppal, N. K., Valenzuela, A. E., Lein, P. J., & Fomina, A. F. (2025) · Cell Calcium · doi:10.1016/j.ceca.2025.103072 · Cited by 3

Changes in peripheral blood and cognitive performance after nonconcussive head impacts in elite female soccer players

Cente, M., Peráčková, J., Peráček, P., Majdán, M., Tóth, I., Mikulič, M., Hanes, J., Špajdel, M., Sivčo, P., Skrabanova, M., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01127-8 · Cited by 6

Piperine Prevents Scopolamine-Induced Cognitive Impairment via its Antioxidant and Anti-Inflammatory Roles; Suggesting Potential Modulation of Necroptosis-Related Genes Including MLKL and TNF-α

Kopi, T. A., Shanehbandpour-Tabari, F., Arani, R. M., Ataie, A., Pouramir, M., & Khaleghzadeh‐Ahangar, H. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02437-1 · Cited by 3

Plasma pTau217/Aβ 42 and pTau217 outperform pTau181/Aβ 42 and pTau181 in predicting cerebrospinal fluid amyloid positivity: A real-world retrospective study

Imperiale, D., Marcinnò, A., Atzori, C., Angeloro, D. P., Murgioni, A., Bagatin, A., Secci, V., Calcagno, A., Capobianco, M. A. N., Moja, M. C., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251390897 · Cited by 3

The locus coeruleus, a blue spot for early diagnosis and prognosis of Alzheimer’s disease

Farahani, F., Anaclet, C., Azizi, H., & Gompf, H. S. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632236 · Cited by 4

Consideration of sex as a biological variable over the history of the 5xFAD Alzheimer’s Disease mouse model

Neuharth, J., Hernandez, K. A., Bernholtz, J., Edwards, H., & Stewart, A. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00788-3 · Cited by 3

Uncovering barriers to early diagnosis of Alzheimer's disease: a European perspective

Pérez‐Martínez, D. A., Jarry, A., Martino, G., Pesce, G., Pieniazek, I., Presto, J., Miernik, P., Casciano, R., & Frederiksen, K. S. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70178 · Cited by 3

ELAVL1 interacts with APP and promotes Aβ-induced apoptosis in Alzheimer's disease by activating Bcl-2/Bax signaling

Fu, J. Q., Ding, C., Li, W., Lei, J., Wang, H., Meng, L., Lin, X., Chen, W., & Gao, H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115613 · Cited by 4

Fe2+-responsive nanomicelle alleviate Alzheimer's disease pathogenesis by targeting the interplay between Aβ deposition and iron overload

Liu, J., Qiao, S., Gong, W., Liu, M., Qifeng, J., Zhang, B., Hui, W., Liu, D., & Zhou, S. Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.173194 · Cited by 3

Lecanemab for treatment of individuals with early Alzheimer’s Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes

Perry, R. J., Kipps, C., Martín, M., Bozzali, M., Logroscino, G., Trafford, S. J., Dhadda, S., Kanekiyo, M., Amanda, G., Hodgkinson, M., et al. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100507 · Cited by 4

Genetic risk in Alzheimer’s disease

Pan, Y., Cho, H., Lou, Q., Zhang, W., Asken, B. M., & Song, Q. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00665-8 · Cited by 3

Spatial navigation as a digital marker for clinically differentiating cognitive impairment severity

Colombo, G., Minta, K., Taylor, W. R., Grübel, J., Chong, E. J. Y., Chong, J. R., Lim, M. J. H., Gonzales, P. N. G., Lai, M. K. P., Chen, C. P., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01484-y · Cited by 8

Protective effects of the natural polyphenol garcinol from Garcinia indica mitigates aluminium chloride-induced Alzheimer’s-like neurodegeneration in Drosophila melanogaster

Kandasamy, K., Narasimhamoorthi, S. P., Arulselvan, P., & Jaganathan, D. (2026) · 3 Biotech · doi:10.1007/s13205-026-04763-6 · Cited by 3

Caregiver-Targeted Online Multicomponent Intervention and Quality of Life in Alzheimer’s Disease: A Randomized Controlled Trial

Muñoz-Padros, J., Garolera, M., Juvanteny, E. P., Bartes-Plans, A., Mas, M. T. R., Roura-Poch, P., & Boreu, Q. F. (2026) · Clinical Gerontologist · doi:10.1080/07317115.2026.2659355 · Cited by 3

Status of Alzheimer’s and Parkinson’s Disease Detections and Treatments

Nguyen, P. H., & Derreumaux, P. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00096 · Cited by 3

Recent Advances in Computational Modeling of BACE1 Inhibitors as Anti-Alzheimer Agents

Papavasileiou, K. D., Dondero, F., Melagraki, G., & Afantitis, A. (2023) · Neuromethods · doi:10.1007/978-1-0716-3311-3_3 · Cited by 3

A review of SaiLuoTong (MLC-SLT) development in vascular cognitive impairment and dementia

Ampil, E. R., Ong, P. A., Krespi, Y., & Yang, Y.-H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1343820 · Cited by 3

Introduction to Alzheimer's Disease, Biomarkers, and the AI Revolution

Yingngam, B. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-3605-2.ch001 · Cited by 3

Structural and molecular features of acetylcholinesterase targeting small molecules: leveraging in silico tools to combat Alzheimer's disease

Haque, A., Alenezi, K. M., & Rasheed, M. S. M. A. (2024) · New Journal of Chemistry · doi:10.1039/d4nj02065k · Cited by 3

Molecular Integrative Study on Inhibitory Effects of Pentapeptides on Polymerization and Cell Toxicity of Amyloid-β Peptide (1–42)

Ye, L., Ajuyo, N. M. C., Wu, Z., Yuan, N., Xiao, Z., Gu, W., Zhao, J., Pei, Y., Min, Y., & Wang, D. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46090606 · Cited by 3

Monoclonal anti-amyloid antibody treatment: the epidemiological profile of the target patients in Austria and the status of treatment-eligible patients registered at an outpatient memory clinic

Lee, S., & Stögmann, E. (2024) · Wiener klinische Wochenschrift · doi:10.1007/s00508-024-02465-8 · Cited by 3

Using Routinely Collected Health Data to Estimate the Prevalence of Alzheimer's Disease and Potentially Modifiable Risk Factors in Colombia

Salazar‐Londoño, S., Silva‐Buriticá, C., Herrera‐Velez, L., & Rosselli, D. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70029 · Cited by 3

Tau Imaging: Use and Implementation in New Diagnostic and Therapeutic Paradigms for Alzheimer’s Disease

Gogola, A., Lopresti, B. J., Minhas, D. S., López, O. L., Cohen, A. D., & Villemagne, V. L. (2025) · Geriatrics · doi:10.3390/geriatrics10010027 · Cited by 4

Design, synthesis, biological evaluation, and X‐ray single crystal structure of novel computer‐aided‐drug‐designbased α‐mangostin derivatives: Multifunctional ligands against Alzheimer's disease

Chen, Q., Li, X., Xiao, W., Sun, Y., Shen, R., Kou, X., & Yang, A. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400671 · Cited by 3

Interaction Between Glucagon-like Peptide 1 and Its Analogs with Amyloid-β Peptide Affects Its Fibrillation and Cytotoxicity

Андреевна, Л. Е., Shevelyova, M. P., Андреевна, В. А., Deryusheva, E. I., Chaplygina, A. V., Rastrygina, V. A., Валериевич, М. А., Alikova, V. D., Nazipova, A. A., Permyakova, M. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094095 · Cited by 3

Highlights of 2024: Beyond lipids: immune dysfunction in APOE4‐associated Alzheimer's disease

McEwan, I., Thomson, S., Issar, J. K., & Finney, C. A. (2025) · Immunology and Cell Biology · doi:10.1111/imcb.70025 · Cited by 3

Assessing Alzheimer's disease knowledge among Egyptian medical students in the context of recent educational reforms

Samir, A. A., Hageen, A. W., Elbarbary, K., Elamir, A. H., Abdel-Fattah, M. A., Alameldin, M. M., Al-Qahtani, F. S., On behalf of the Alzheimer’s group of Egypt, Elsharkawy, S., Mohamed, M. F., et al. (2025) · BMC Medical Education · doi:10.1186/s12909-025-07258-9 · Cited by 3

Detection of Alzheimer’s Disease progression from Structural MRIs using ConvMixer based Deep Learning Model

Lashkary, M., Bansal, K., Jain, S., Shukla, P. K., Tekchandani, H., & Dhaka, V. S. (2025) · Procedia Computer Science · doi:10.1016/j.procs.2025.04.278 · Cited by 4

Brain derived neurotrophic factor and secreted amyloid precursor protein‐α response to moderate and high intensity exercise

Spencer, F. S. E., Elsworthy, R. J., Breen, L., Bishop, J. R. B., Lucas, S. J. E., & Aldred, S. (2025) · Physiological Reports · doi:10.14814/phy2.70366 · Cited by 4

Plasma FGF2 and YAP1 as novel biomarkers for MCI in the elderly: analysis via bioinformatics and clinical study

Zhao, Y., Wang, X., Zhang, J., Zhao, Y., Li, Y., Shen, J., Yuan, Y., & Li, J. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1663276 · Cited by 4

Multi-omics integration reveals key miRNAs, immune inflammation, and signaling pathways in Alzheimer's disease: Implications for targeted therapy

Wang, G., Duan, J., Sun, L., Pan, S., Liu, Q., Fu, K., Zhang, D., Yuan, X., Fan, B., Hu, B., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147874 · Cited by 3

Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease

Saposnik, G., Sánchez‐Benavides, G., García-Arcelay, E., Macías, E. F., Bensi, C., Carmelingo, S., Allegri, R., Pérez-Martínez, D. A., & Mauriño, J. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00466-9 · Cited by 4

Computational Fragment‐Based Design of Phytochemical Derivatives as EGFR Inhibitors

Bhat, G. S., & Mohammad, F. S. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300681 · Cited by 3

Synthetic β-sheets mimicking fibrillar and oligomeric structures for evaluation of spectral X-ray scattering technique for biomarker quantification

Suresh, K., Dahal, E., & Badano, A. G. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01208-6 · Cited by 3

Gonadal hormone deprivation regulates response to tibolone in neurodegenerative pathways

McGovern, A. J., Arévalo, M., Ciordia, S., García‐Segura, L. M., & Barreto, G. E. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106520 · Cited by 3

The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection

Tabatabaei‐Malazy, O., Azizi, B., & Abdollahi, M. R. (2024) · Handbook of experimental pharmacology · doi:10.1007/164_2024_732 · Cited by 3

Associations of high-sensitivity C-reactive protein with neuropsychological outcomes and cerebral white matter hyperintensities in older adults at risk of dementia

Yu, R., Kong, S. D. X., Ireland, C., Steiner-Lim, G. Z., Bassett, K., Almgren, H., Wang, D., Wang, C., Michaelian, J. C., & Naismith, S. L. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100924 · Cited by 4

Therapeutic Potential of Experimental Stereotactic Hippocampal Cell Transplant in the Management of Alzheimer’s Disease

Agavriloaei, L. M., Iliescu, B. F., Pintilie, R. M., & Turliuc, M. D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030891 · Cited by 4

Sex differences in the confounders influencing the relationships linking socioeconomic factors and cognitive performance with family history of Alzheimer's disease and related dementias

He, J., Cabrera‐Mendoza, B., Friligkou, E., Mecca, A. P., van Dyck, C. H., Pathak, G. A., & Polimanti, R. A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70215 · Cited by 4

Surgical advances in the treatment of Alzheimer's disease: A comprehensive review

Xie, F., Ye, Y., Hao, J., Liu, H., Richard, S. A., & Sen, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251364397 · Cited by 3

The psychological impact of the disclosure of the diagnosis of Alzheimer's disease on informal caregivers

Solorzano, C. S., Bonomini, C., Rosini, S., Passeggia, I., Zanetti, O. O., Pievani, M., Frisoni, G. B., & Festari, C. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70412 · Cited by 3

Alzheimer's detection by Artificial Bee Colony and Convolutional Neural Network at Mobile Environment

Shan, D., Shi, F., & Le, T. (2024) · Mobile Networks and Applications · doi:10.1007/s11036-024-02313-z · Cited by 3

EMPOWERING SELF-DETECTION: A GRAPHICAL USER INTERFACE POWERED BY MACHINE LEARNING FOR EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE

Kabakuş, A. T., & Erdoğmuş, P. (2024) · İstanbul Ticaret Üniversitesi Fen Bilimleri Dergisi · doi:10.55071/ticaretfbd.1416508 · Cited by 2

Comparing the Hippocampal Volume Between Patients with Alzheimer’s Disease and Healthy Controls: An MRI Analysis using the Harmonized Hippocampal Protocol

Hải, N. T., Huynh, T., Nguyen, M., Nguyen, H., Bui, L. C., Ta, T. M., Nguyen, H. X., & Ha, H. (2024) · Brain Science Advances · doi:10.26599/bsa.2024.9050009 · Cited by 2

Decreased Expression of Alzheimer’s Disease-Related Genes in Cancer May Contribute to the Inverse-Relationship-a Computational Study

Anyomi, B. K., Fosu, K., Lamptey, E. L., Agegnehu, S. B., Quarshie, J. T., Kampo, S., & Wei, J. (2025) · ACS Omega · doi:10.1021/acsomega.4c11571 · Cited by 2

Outcome measurement instruments in neurodegenerative diseases: Comprehensive analysis and platform construction

Zong, H., Cha, J., Tao, L., Shi, M., Zhao, Y., Zhang, R., & Shen, B. (2025) · Digital Health · doi:10.1177/20552076251335544 · Cited by 2

Biomarker-Driven Diagnosis in Neurocognitive Disorders

Cabreira, V., & Isaacs, J. D. (2025) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200481 · Cited by 2

Synthesis and characterization of a new Carbon-11 labeled positron emission tomography radiotracer for RIPK1 neuroimaging

Cheng, H., Wang, Y., Wang, Y., Dagnew, T. M., Siewko, A., Varela, B. L., Ma, P., Hallisey, M. R., Cheng, A., Wang, C., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110324 · Cited by 2

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study

Xu, J., Zhao, N., Wang, Y., Gueorguieva, I., Qian, C., & Cui, Y. (2025) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1533 · Cited by 2

Strategic multimodal intervention in at-risk elderly Indians for prevention of dementia (SMRUTHI INDIA): a cohort multiple randomised controlled trial (cmRCT) protocol

Gupta, A., Sinha, A., Sharma, V., Raina, S., Roy, S., Baidya, S., Anand, P. K., Nehra, A., Nilima, N., Khan, M. A., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-084050 · Cited by 2

The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study

Ochneva, A., Zakurazhnaya, V., Zorkina, Y., Abramova, O. V., Ushakova, V. M., Tsurina, A. M., Golubeva, E., Gurina, O. I., Berdalin, A., Syunyakov, T., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251350385 · Cited by 2

Click Chemistry‐Aided Synthesis of Triazole‐Tethered Benzothiazoles as Novel Multifunctional Agents Against Alzheimer's Disease

Elbadawi, M. M., Elgazar, A. A., Hefny, A. A., Abdulla, M., Traiki, T. B., Roshdy, E., Al-Sanea, M. M., Abe, M., Eldehna, W. M., Rao, P. P. N., et al. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70046 · Cited by 2

Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective

Watermeyer, T., & Calia, C. (2019) · Journal of Global Health · doi:10.7189/jogh.09.010317 · Cited by 28

Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia

Mar, J., Soto‐Gordoa, M., Arrospide, A., Moreno, F., & Martínez‐Lage, P. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0079-9 · Cited by 31

Estimating prevalence of early symptomatic Alzheimer's disease in the United States

Spargo, D., Zur, R., Lin, P., Synnott, P., Klein, E., & Hartry, A. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12497 · Cited by 9

O4‐13‐06: NEW GLOBAL PREVALENCE DATA ON DEMENTIA

Wortmann, M. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.528 · Cited by 3

PND59 Estimating the Prevalence of Aβ-Confirmed Alzheimer's Disease Using a Funnel-Based Approach

Potashman, M. H., Benea, M. L., Gillis, C., Gianinazzi, M., Ikram, M. A., & Maserejian, N. N. (2020) · Value in Health · doi:10.1016/j.jval.2020.08.1384 · Cited by 3